within Pharmacolibrary.Drugs.ATC.D;

model D08AK01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.05,
    Cl             = 0.00025,
    adminDuration  = 600,
    adminMass      = 0.01,
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Mercuric amidochloride, also known as mercuric chloride ammonia (NH2HgCl, formerly 'ammoniated mercury'), is an inorganic mercury compound historically used as a topical antiseptic and disinfectant in dermatology. Its use has largely been discontinued due to significant toxicity and potential for mercury poisoning; it is not approved for modern clinical use due to safety concerns.</p><h4>Pharmacokinetics</h4><p>No formal pharmacokinetic studies in humans are available for mercuric amidochloride. Estimates are based on general mercury compound absorption and distribution patterns. Data are not specific to gender, age, or condition.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D08AK01;
